Promoters hold 72.0% of Tatva Chintan Pharma Chem Limited (TATVA). FIIs hold 3.9%, mutual funds 2.8% and other DIIs 0.3%. No promoter pledge is reported. Quarterly shareholding, quarter ended Jun 26.
Folio counts aren't part of the shareholding pattern we ingest today — they arrive with a later filing parse.
| Holder | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 72.0% | 72.0% | 72.0% | 72.0% | 72.0% | 72.0% | 72.0% | 72.0% | 72.0% | 72.0% | 72.0% | 72.0% |
| FII | 3.9% | 3.8% | 4.2% | 3.4% | 3.3% | 3.3% | 3.4% | 3.3% | 3.4% | 3.6% | 4.2% | 4.4% |
| MF | 2.8% | 2.9% | 3.3% | 3.8% | 5.1% | 5.3% | 6.3% | 6.8% | 10.6% | 12.8% | 13.1% | 13.5% |
| Other DII | 0.3% | 0.1% | 0.1% | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 0.3% |
| Retail & others | 20.9% | 21.2% | 20.5% | 20.7% | 19.6% | 19.2% | 18.3% | 17.8% | 14.0% | 11.5% | 10.7% | 9.8% |
No bulk or block deals disclosed for this stock in the last 90 days.
Bulk deals are uncommon for large caps — a single client has to trade over 0.5% of the company's shares in one day. Most weeks, none happen.
Promoters hold 72.02% as of Jun 26; institutional ownership was broadly unchanged this quarter.
Quarterly shareholding patternas of Jun 26
